Management of heart failure: Ambition and reality in the early 21st century;Behandlung der herzinsuffizienz: Wunsch und wirklichkeit zu beginn des 21. Jahrhunderts

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 97, Issue 2, 2003, Pages 98-103

  Dietz, Rainer ^a,b   Osterziel, Karl Josef ^a   Cleland, John G F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Evidence based medicine; Heart failure; Improvement of heart failure initiative

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL PRACTICE; DIAGNOSTIC TEST; ENZYME INHIBITION; HEALTH CARE NEED; HEART FAILURE; HUMAN; PATIENT CARE; PRIMARY MEDICAL CARE; REVIEW;

DELIVERY OF HEALTH CARE; GERMANY; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0037620407     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Braunwald E, Bristow J (2000) Congestive Heart Failure: Fifty Years of Progress. Circulation 102: IV14-IV23
2. Chin MH, Friedmann PD, Cassel CK, Lang RM (1997) Differences in generalist and specialist physicians knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med 12: 523-530
3. Cleland JGF (1994) The clinical course of heart failure and ist modification by ACE inhibitors: insights from recent clinical trials. Eur Heart J 15: 125-140
4. Cleland, J.G.F (1995) ACE inhibitors for the prevention and treatment of heart failure: Why are they "under-used"? J Hum Hypertens 9: 435-442,
5. Cleland JGF, Swedberg K, Poole-Wilson PA (1998) Successes and failures of current treatmant of heart failure. Lancet 352 (suppl 1): SI19-SI28
6. Cleland et al (1999) BMJ
7. Cleland JG. Swedberg K, Cohen Solal A, Cosin Aguilar J, Dietz R, Follath F, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Preda I, van Gilst WH, Widimsky J, Mareev V, Mason J, Freemantle N, Eastaugh J (2000) The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2: 123-132
8. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DR (1997) The epidemiology of heart failure. European Heart Journal 18: 208-225
9. Effects of enalapril on mortality in severe congestive heart failure (1987) Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316: 1429-1435
10. European Secundary Prevention Study) (Woods KL, Ketley D, Lowy A et al (1998) Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. Eur Heart J 19: 74-79
11. Guidelines for the diagnostics of heart failure (1995) The Force on Heart Failure of the European Cociety of Cardiology. Eur Heart J 16: 741-51). (McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The Natural History of Congestive Heart Failure: The Framingham Study. New England Journal of Medicine 285: 1441-1446
12. Guidelines for the diagnostics of heart failure (1995) The Force on Heart Failure of the European Cociety of Cardiology. Eur Heart J 16: 741-51). (McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The Natural History of Congestive Heart Failure: The Framingham Study. New England Journal of Medicine 285: 1441-1446
13. Ho KKL, Anderson KM, Kannel WB, Grossmann W, Levy D (1993) Survial after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88: 107-115
14. Investigators TS (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine 327: 685-691
15. MCDonagh TA, Morrison CE, Lawrence A et al (1997) Symtomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.. Lancet 350: 829-833
16. Remes J, Miettinen H, Reunanen A, Pyorala K (1991) Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12: 315-321
17. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen ST, Evans JM, Baily KR, Redfield MM (1998) Congestive heart failure in the Community. Circulation 98: 2282-2289
18. Stewart AL, Greenfield S, Hays RD et al (1999) Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 262: 907-913
19. The Task Force on Heart Failure of the European Society of Cardiology (1997) Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-751 und The Task Force of the Working Group in Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 18: 736-753
20. The Task Force on Heart Failure of the European Society of Cardiology (1997) Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-751 und The Task Force of the Working Group in Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 18: 736-753
21. U. S. Department of Health and Human Services (1994) Mortality from Congestive Heart Failure - United States 1980-1990. Morbidity and Mortality Weekly Report 43: 77-81